<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ETM</journal-id>
<journal-title-group>
<journal-title>Experimental and Therapeutic Medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">1792-0981</issn>
<issn pub-type="epub">1792-1015</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/etm.2016.3667</article-id>
<article-id pub-id-type="publisher-id">ETM-0-0-3667</article-id>
<article-categories>
<subj-group>
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Obesity and hypertension</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Jiang</surname><given-names>Shu-Zhong</given-names></name>
<xref rid="af1-etm-0-0-3667" ref-type="aff"/>
<xref rid="c1-etm-0-0-3667" ref-type="corresp"/></contrib>
<contrib contrib-type="author"><name><surname>Lu</surname><given-names>Wen</given-names></name>
<xref rid="af1-etm-0-0-3667" ref-type="aff"/></contrib>
<contrib contrib-type="author"><name><surname>Zong</surname><given-names>Xue-Feng</given-names></name>
<xref rid="af1-etm-0-0-3667" ref-type="aff"/></contrib>
<contrib contrib-type="author"><name><surname>Ruan</surname><given-names>Hong-Yun</given-names></name>
<xref rid="af1-etm-0-0-3667" ref-type="aff"/></contrib>
<contrib contrib-type="author"><name><surname>Liu</surname><given-names>Yi</given-names></name>
<xref rid="af1-etm-0-0-3667" ref-type="aff"/></contrib>
</contrib-group>
<aff id="af1-etm-0-0-3667">Department of Cardiology, Xuzhou Central Hospital, Xuzhou, Jiangsu 221009, P.R. China</aff>
<author-notes>
<corresp id="c1-etm-0-0-3667"><italic>Correspondence to</italic>: Dr Shu-Zhong Jiang, Department of Cardiology, Xuzhou Central Hospital, 199 Jiefang South Road, Xuzhou, Jiangsu 221009, P.R. China, E-mail: <email>rhl737@163.com</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>10</month>
<year>2016</year></pub-date>
<pub-date pub-type="epub">
<day>06</day>
<month>09</month>
<year>2016</year></pub-date>
<volume>12</volume>
<issue>4</issue>
<fpage>2395</fpage>
<lpage>2399</lpage>
<history>
<date date-type="received"><day>11</day><month>12</month><year>2015</year></date>
<date date-type="accepted"><day>19</day><month>08</month><year>2016</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x00A9; Jiang et al.</copyright-statement>
<copyright-year>2016</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license>
</permissions>
<abstract>
<p>The imbalance between energy intake and expenditure is the main cause of excessive overweight and obesity. Technically, obesity is defined as the abnormal accumulation of &#x2265;20&#x0025; of body fat, over the individual&#x0027;s ideal body weight. The latter constitutes the maximal healthful value for an individual that is calculated based chiefly on the height, age, build and degree of muscular development. However, obesity is diagnosed by measuring the weight in relation to the height of an individual, thereby determining or calculating the body mass index. The National Institutes of Health have defined 30 kg/m<sup>2</sup> as the limit over which an individual is qualified as obese. Accordingly, the prevalence of obesity in on the increase in children and adults worldwide, despite World Health Organization warnings. The growth of obesity and the scale of associated health issues induce serious consequences for individuals and governmental health systems. Excessive overweight remains among the most neglected public health issues worldwide, while obesity is associated with increasing risks of disability, illness and death. Cardiovascular diseases, the leading cause of mortality worldwide, particularly hypertension and diabetes, are the main illnesses associated with obesity. Nevertheless, the mechanisms underlying obesity-associated hypertension or other associated metabolic diseases remains to be adequately investigated. In the present review, we addressed the association between obesity and cardiovascular disease, particularly the biological mechanisms linking obesity and hypertension.</p>
</abstract>
<kwd-group>
<kwd>obesity</kwd>
<kwd>hypertension</kwd>
<kwd>renin-angiotensin system</kwd>
<kwd>body mass index</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<label>1.</label>
<title>Introduction</title>
<p>Obesity is traditionally defined as a weight &#x2265;20&#x0025; above the ideal weight, which corresponds to the lowest death rate for individuals of a specific height, gender and age (<xref rid="b1-etm-0-0-3667" ref-type="bibr">1</xref>). More recent guidelines for obesity have introduced the use of a measurement known as body mass index (BMI), which is calculated by the individual&#x0027;s weight multiplied by 703 and divided by twice the height in inches. The value of BMI is now used to diagnose the stage of overweight or obesity thereby fixing at 25.9&#x2013;29 the limited BMI considered as overweight, while a BMI &#x003E;30 constitutes obesity (<xref rid="b2-etm-0-0-3667" ref-type="bibr">2</xref>). According to the World Health Organization (WHO), in 2005, approximately 1.6 billion adults over the age of 15 were overweight (<xref rid="b3-etm-0-0-3667" ref-type="bibr">3</xref>). At least 400 million adults were considered obese and &#x2265;20 million children under the age of 5 years were overweight. The estimation for the current year (2015) is approximately 2.3 billion overweight adults and over 700 million obese ones (<xref rid="b4-etm-0-0-3667" ref-type="bibr">4</xref>). WHO defines &#x2018;globesity&#x2019; as a worldwide epidemic of obesity that is currently on the increase. The situation is critical due to the fact that the diseases that can occur due to obesity are becoming increasingly prevalent, particularly cardiovascular diseases, currently the leading cause of mortality worldwide (<xref rid="b5-etm-0-0-3667" ref-type="bibr">5</xref>).</p>
<p>Obesity can result in serious health issues that are potentially life threatening, including hypertension, type II diabetes mellitus, increased risk for coronary disease, increased unexplained heart failure, hyperlipidemia, infertility, higher prevalence of colon, prostate, endometrial, and breast cancer (<xref rid="b6-etm-0-0-3667" ref-type="bibr">6</xref>,<xref rid="b7-etm-0-0-3667" ref-type="bibr">7</xref>). Although the relationship between obesity and hypertension is well established in children and adults (<xref rid="b8-etm-0-0-3667" ref-type="bibr">8</xref>&#x2013;<xref rid="b11-etm-0-0-3667" ref-type="bibr">11</xref>), the mechanism by which obesity directly causes hypertension is under investigation (<xref rid="b12-etm-0-0-3667" ref-type="bibr">12</xref>,<xref rid="b13-etm-0-0-3667" ref-type="bibr">13</xref>). Activation of the sympathetic nervous system (SNS), the amount of intra-abdominal and intra-vascular fat, sodium retention leading to increase in renal reabsorption, and the renin-angiotensin system, are considered to have important functions in the pathogenesis of obesity-related hypertension, a chronic medical condition in which the blood pressure is persistently at or &#x003E;140/90 mmHg but not at the normal level which is defined as 100&#x2013;140 and 60&#x2013;90 mmHg for systolic and diastolic pressure, respectively. Accordingly, obesity can be considered a complex and chronic medical condition that requires deep understanding, particularly for the mechanisms leading to hypertension to plan successful treatment strategies. The present review examines the potential mechanisms by which obesity can lead to elevated arterial blood pressure and how management of obesity constitutes a therapeutical strategy for the treatment of hypertension.</p>
</sec>
<sec>
<label>2.</label>
<title>Obesity and hypertension</title>
<sec>
<title/>
<sec>
<title>Global causes of obesity and consequences</title>
<p>There is no single cause to explain all the cases of obesity worldwide. Environmental factors associated with obesity include socioeconomic status, ethnicity, region of residence, season, and urban living (<xref rid="b14-etm-0-0-3667" ref-type="bibr">14</xref>). Nevertheless, obesity ultimately results from an imbalance between energy intake and energy expenditure (<xref rid="b15-etm-0-0-3667" ref-type="bibr">15</xref>). Genetic predisposition may be a determinant for weight gain; however, previous findings have shown that genetic predisposition does not automatically lead to the development of obesity, because eating habits and patterns of physical activity may play a more significant role in the amount of weight gained (<xref rid="b16-etm-0-0-3667" ref-type="bibr">16</xref>,<xref rid="b17-etm-0-0-3667" ref-type="bibr">17</xref>). In addition, a sedentary lifestyle as well as psychological factors such as depression, low esteem, or absence of night sleep can also largely contribute to weight gain (<xref rid="b18-etm-0-0-3667" ref-type="bibr">18</xref>). However, although the exact cause of weight gain remains to be clarified and likely arises from a complex combination of factors such as genetic factors that greatly affect the manner in which the body regulates the appetite, and the rate at which it turns food into energy, known as the metabolic rate (<xref rid="b19-etm-0-0-3667" ref-type="bibr">19</xref>,<xref rid="b20-etm-0-0-3667" ref-type="bibr">20</xref>), excessive weight is clearly gained by consuming an excess of calories as compared to those utilized by the body, with the excess of calories being stored as fat tissue (<xref rid="b15-etm-0-0-3667" ref-type="bibr">15</xref>).</p>
<p>Accordingly, the quantity of fat in a person&#x0027;s diet may have greater impact on weight than the number of calories it contains. The majority of fat calories are immediately stored in fat cells, which add to the body&#x0027;s weight and girth as they expand and multiply (<xref rid="b21-etm-0-0-3667" ref-type="bibr">21</xref>) while carbohydrates such as cereals, breads, fruits, and vegetable and proteins are converted to fuel almost immediately following consumption (<xref rid="b22-etm-0-0-3667" ref-type="bibr">22</xref>). In addition, fat regimens result in excessive and abnormally higher levels of cholesterol in the blood (hypercholesterolemia) (<xref rid="b23-etm-0-0-3667" ref-type="bibr">23</xref>). Depending on the balance between the fractions of saturated and unsaturated fatty acids, fat contained in the blood circulation can immediately affect certain organs such as liver and kidney, concomitantly with devastating local actions inside of the vessels through the formation of atherosclerosis (<xref rid="b24-etm-0-0-3667" ref-type="bibr">24</xref>), an infringement of medium and large arteries due to a buildup of fat inside of the arterial wall, termed visceral fat. The latter is mainly involved in metabolic syndrome (<xref rid="b25-etm-0-0-3667" ref-type="bibr">25</xref>).</p>
<p>Diets that are extremely rich in carbohydrates and high doses of alcohol promote the increase of another lipid component present in the blood, that of triglycerides, which constitures an additional risk factor of the formation of atherosclerosis (<xref rid="b24-etm-0-0-3667" ref-type="bibr">24</xref>). Other factors favoring the formation of atherosclerosis include physical inactivity, smoking, stress, inflammation and certain bacteria (<xref rid="b26-etm-0-0-3667" ref-type="bibr">26</xref>). However, the fat continually accumulated in branch vessels, thus blocking the blood flow of large arteries. In agreement with these data, increased carotid intima-media thickness in obese subjects independently of blood pressure levels, even in a normotensive blood pressure range has been observed (<xref rid="b27-etm-0-0-3667" ref-type="bibr">27</xref>). This observation suggests an early course of the atherosclerotic process in obesity. Accumulation gradually increases to form a type of plaque that may continue to grow until it reaches a narrowing or stenosis of the vascular wall (<xref rid="b28-etm-0-0-3667" ref-type="bibr">28</xref>) that can continue to increase until important obstructions of arterial lumen are induced and downstream local disorders that affect organs are generated, leading to morbidity (<xref rid="b29-etm-0-0-3667" ref-type="bibr">29</xref>,<xref rid="b30-etm-0-0-3667" ref-type="bibr">30</xref>) and even sudden death (<xref rid="b31-etm-0-0-3667" ref-type="bibr">31</xref>). Another detrimental effect of high caloric intake is the increase of norepinephrine turnover in peripheral tissues, raising the resting plasma norepinephrine concentration, which is an indirect measurement of SNS activity, and amplifying the increase of plasma norepinephrine in response to stimuli such as upright posture (<xref rid="b32-etm-0-0-3667" ref-type="bibr">32</xref>). Thus, high dietary content in fat and carbohydrate has been suggested to acutely stimulate peripheral &#x03B1;1 and &#x03B2;-adrenergic receptors thereby leading to the elevation of sympathetic activity and hypertension (<xref rid="b33-etm-0-0-3667" ref-type="bibr">33</xref>). Similarly, upregulated hypothalamic tyrosine hydroxylase and hypothalamic adrenoceptor gene expression of the &#x03B1;2B receptor have been identified, in obese hypertensive rat (<xref rid="b34-etm-0-0-3667" ref-type="bibr">34</xref>). In addition, the pharmacological blockade of adrenergic activity in experimental models markedly decreased the rise of blood pressure in dogs fed a high-fat diet (<xref rid="b10-etm-0-0-3667" ref-type="bibr">10</xref>). Similarly, in human, combined &#x03B1; and &#x03B2; adrenergic blockade significantly reduced blood pressure in obese relative to lean patients with essential hypertension (<xref rid="b35-etm-0-0-3667" ref-type="bibr">35</xref>), although elevated heart rate seems to be the effect of decreased parasympathetic activity (<xref rid="b36-etm-0-0-3667" ref-type="bibr">36</xref>).</p>
<p>Overweight is a condition that affects the body composition thereby damaging and modifying the aspects of organs. Major organs feeling the brunt of obesity, include heart (<xref rid="b37-etm-0-0-3667" ref-type="bibr">37</xref>), liver (<xref rid="b38-etm-0-0-3667" ref-type="bibr">38</xref>), kidney (<xref rid="b39-etm-0-0-3667" ref-type="bibr">39</xref>), lungs (<xref rid="b40-etm-0-0-3667" ref-type="bibr">40</xref>), colon (<xref rid="b41-etm-0-0-3667" ref-type="bibr">41</xref>), skin (<xref rid="b42-etm-0-0-3667" ref-type="bibr">42</xref>), vessels (<xref rid="b43-etm-0-0-3667" ref-type="bibr">43</xref>) and brain (<xref rid="b44-etm-0-0-3667" ref-type="bibr">44</xref>). Whereas the effect on each organ is associated with collateral defects that may have serious concerns regarding health, renal injury seems, however, to be the most directly dependent on body weight, as dietary fat restriction ameliorates significantly the renal histology (<xref rid="b45-etm-0-0-3667" ref-type="bibr">45</xref>). The structural changes inside of the kidney, secondary to obesity, are important as the fat deposit around the kidneys, together with increased abdominal pressure secondary to central obesity, have been suggested as an additional cause of renal sodium reabsorption disorder. Specifically, initially, obesity causes renal vasodilatation and glomerular hyperfiltration, which act as a compensatory mechanism to maintain sodium balance despite the increased tubular reabsorption that, along with increased arterial blood pressure and metabolic abnormalities as well as other factors such as inflammation, oxidative stress, and lipotoxicity, may contribute to the exacerbation of renal injury or dysfunction through a vicious cycle (<xref rid="b46-etm-0-0-3667" ref-type="bibr">46</xref>,<xref rid="b47-etm-0-0-3667" ref-type="bibr">47</xref>). These factors result in clinical evidence of the presence of proteinuria that usually precedes the glomerular filtration rate decline over several years (<xref rid="b48-etm-0-0-3667" ref-type="bibr">48</xref>,<xref rid="b49-etm-0-0-3667" ref-type="bibr">49</xref>). The involvement of insulin and angiotensin II in the development of glomerular hyperfiltration have been shown in obese animals (<xref rid="b42-etm-0-0-3667" ref-type="bibr">42</xref>) in which, leptin, a hormone produced in adipose tissue, contributes to the development of renal injury through the induction of cytokines (<xref rid="b50-etm-0-0-3667" ref-type="bibr">50</xref>). Consistently, adipose tissues, particularly those of abdominal fat may specifically exert systemic effects through the secretion of a variety of hormones and cytokines, leading to obese-associated glomerulopathy (<xref rid="b51-etm-0-0-3667" ref-type="bibr">51</xref>).</p>
<p>In accordance to the abovementioned data, regimens rich in fat and carbohydrate, lead to hypercholesterolemia and free-fatty acids in the blood (<xref rid="b23-etm-0-0-3667" ref-type="bibr">23</xref>) which together with free-fatty acids released from phospholipids can act directly on ion channels of cellular membranes of smooth muscle cells and other tissues (<xref rid="b52-etm-0-0-3667" ref-type="bibr">52</xref>). They can also act as potent activators of the phosphorylation of calcium-independent isoenzyme of protein kinase C (<xref rid="b53-etm-0-0-3667" ref-type="bibr">53</xref>), a vital element in mediating signal transduction and cell regulation. The binding of free-fatty acid to NA/K-ATPase is involved in the changes of interactions between the enzyme and neighboring membrane protein to induce the formation of multiple signaling modules that results in the activation and production of the epidermal growth factor receptor that increased reactive oxygen species (<xref rid="b54-etm-0-0-3667" ref-type="bibr">54</xref>). The reduction of endothelial function is mainly the result of a decrease in nitric oxide (NO) related to an increase in oxidative stress or the result from pro-inflammatory cytokines (<xref rid="b55-etm-0-0-3667" ref-type="bibr">55</xref>). Altogether, cytokines and oxidative stress as well as the decrease of NO result in vasoconstriction and vascular resistance that are detrimental and predisposed to venous insufficiency, venous thrombosis and pulmonary embolus, cardiovascular disease and particularly to hypertension (<xref rid="b37-etm-0-0-3667" ref-type="bibr">37</xref>).</p>
<p>Biochemical, physiological and functional studies have suggested that the renin-angiotensin system is mainly involved in the development of hypertension through two systems including tissue and circulating (<xref rid="b55-etm-0-0-3667" ref-type="bibr">55</xref>). In agreement with this finding, adipose tissue-derived angiotensinogen, the major site in which all components of the RAS are formed, can enter the circulation. The tissue RAS was in a state of constant interaction with the blood. Angiotensinogen, angiotensin (Ang) I and AngII are locally produced and at are simultaneously taken up by the cells, in which AngII receptors are overexpressed. Angiotensinogen production serves as a cause and effect of adipocyte hypertrophy and leads to elevation of blood pressure through the action of AngII, which induces systematic vasoconstriction, direct sodium and water retention and increased aldosterone production (<xref rid="b56-etm-0-0-3667" ref-type="bibr">56</xref>). Consequently, AngII determines a high salt-sensitive blood pressure condition in obesity as it is produced at high rates and is not suppressed by volume expansion. An alternative mechanism of RAS activation may be a chronic elevation of sympathetic tone, causing renal vasoconstriction and renin-dependent chronic hypertension. The arterial blood pressure controlling mechanism of diuresis and natriuresis according to the principle of infinite feedback gain seems to be raised near the higher blood pressure value in obese patients. Abnormalities in these mechanisms tend to raise blood pressure, increase sodium and water excretion through pressure natriuresis and diuresis (<xref rid="b57-etm-0-0-3667" ref-type="bibr">57</xref>), which lead to extracellular fluid volume expansion, resulting in a hypertensive adjustment of the pressure natriuresis (<xref rid="b10-etm-0-0-3667" ref-type="bibr">10</xref>,<xref rid="b11-etm-0-0-3667" ref-type="bibr">11</xref>), a resetting of the kidney fluid apparatus to a hypertensive level, consistent with the model of hypertension because of volume overload. Another significant cause of the shift of pressure natriuresis towards higher blood pressure levels in obesity is the possibility of alterations in intrarenal forces caused by histological changes in the renal medulla that may compress the loops of Henle and vasa recta (<xref rid="b58-etm-0-0-3667" ref-type="bibr">58</xref>).</p>
<p>Furthermore, high levels of plasma renin activity, plasma AngII and aldosterone values were observed in human obesity (<xref rid="b59-etm-0-0-3667" ref-type="bibr">59</xref>) in which a presynaptic potentiating effect was observed on the sympathetic neurotransmission in patients under sodium restriction (<xref rid="b60-etm-0-0-3667" ref-type="bibr">60</xref>), likely through hypothetical mechanisms including impaired function of baroreceptors sensitivity and increased levels of circulating free-fatty acids, AngII, insulin and leptin (<xref rid="b61-etm-0-0-3667" ref-type="bibr">61</xref>).</p>
<p>Elevated levels and abnormally distributed free-fatty acids were reported in obese hypertensive in which they enhanced vascular &#x03B1;-adrenergic sensitivity and consequently the increase of &#x03B1;-adrenergic tone (<xref rid="b62-etm-0-0-3667" ref-type="bibr">62</xref>). Although the mechanisms were endogenous, the effect exerted by free-fatty remains to be investigated. At present, it has been documented that free-fatty acids inhibit Na&#x002B;, K&#x002B; ATPase and the sodium pump raising vascular smooth muscle tone and resistance (<xref rid="b54-etm-0-0-3667" ref-type="bibr">54</xref>).</p>
</sec>
</sec>
</sec>
<sec>
<label>3.</label>
<title>Treatment of obesity-induced hypertension</title>
<p>Although antihypertensive drugs, including RAS blockers, &#x03B2;-blockers, and diuretic drugs, particularly at high doses are eligible for obese hypertensive patients, they provide significant side effects including hyperglycemia, hyperlipidemia and hyperuricemia. Therapeutic approaches of hypertension-induced obesity required the management of the component obesity. The treatment of obesity itself requires guidelines suggesting deep lifestyle modifications aiming to reduce body weight, thereby consuming a low-caloric diet with a total of 500&#x2013;1,500 or 500&#x2013;1,200 calories for men or women, respectively. This may include the restriction of salt intake and lower intake of saturated fats and cholesterol with increased consumption of water, fruits, fresh and raw vegetables, fish, lean meats, whole grain, and/or moderate and constant physical activity as well as adequate night sleep (<xref rid="b63-etm-0-0-3667" ref-type="bibr">63</xref>,<xref rid="b64-etm-0-0-3667" ref-type="bibr">64</xref>). The aim of these habits and activities involve the increase and strengthening of muscular mass vs. decreasing fat mass.</p>
</sec>
<sec sec-type="conclusions">
<label>4.</label>
<title>Conclusion</title>
<p>Obesity is a major risk for essential hypertension, diabetes and other morbidity that contribute to the development of kidney disease because it mainly increases tubular reabsorption to impair pressure natriuresis and cause volume expansion via the activation of the SNS and the RAS. Additionally, obesity causes cardiovascular and renal diseases through several mechanisms including hypertension, hyperglycemia, inflammation, dyslipidemia and atherosclerosis, which are disorders that can coexist, particularly in the presence of excess visceral fat to cause metabolic syndrome (<xref rid="b65-etm-0-0-3667" ref-type="bibr">65</xref>) and are characterized by alteration in fat metabolism through lipid accumulation. Therefore, the habit of regular diets with content of plenty of fiber, &#x03C9;-3, good vegetable and animal proteins, antioxidant, less fat and sugar, vitamins and regular exercise, are healthy practices allowing the body&#x0027;s nutritional signaling mechanisms to equilibrate to reference levels.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="b1-etm-0-0-3667"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crawford</surname><given-names>DA</given-names></name><name><surname>Jeffery</surname><given-names>RW</given-names></name><name><surname>French</surname><given-names>SA</given-names></name></person-group><article-title>Television viewing, physical inactivity and obesity</article-title><source>Int J Obes Relat Metab Disord</source><volume>23</volume><fpage>437</fpage><lpage>440</lpage><year>1999</year><pub-id pub-id-type="doi">10.1038/sj.ijo.0800845</pub-id><pub-id pub-id-type="pmid">10340824</pub-id></element-citation></ref>
<ref id="b2-etm-0-0-3667"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitahara</surname><given-names>CM</given-names></name><name><surname>Flint</surname><given-names>AJ</given-names></name><name><surname>de Gonzalez</surname><given-names>A Berrington</given-names></name><name><surname>Bernstein</surname><given-names>L</given-names></name><name><surname>Brotzman</surname><given-names>M</given-names></name><name><surname>MacInnis</surname><given-names>RJ</given-names></name><name><surname>Moore</surname><given-names>SC</given-names></name><name><surname>Robien</surname><given-names>K</given-names></name><name><surname>Rosenberg</surname><given-names>PS</given-names></name><name><surname>Singh</surname><given-names>PN</given-names></name><etal/></person-group><article-title>Association between class III obesity (BMI of 40-59 kg/m<sup>2</sup>) and mortality: A pooled analysis of 20 prospective studies</article-title><source>PLoS Med</source><volume>11</volume><fpage>e1001673</fpage><year>2014</year><pub-id pub-id-type="doi">10.1371/journal.pmed.1001673</pub-id><pub-id pub-id-type="pmid">25003901</pub-id></element-citation></ref>
<ref id="b3-etm-0-0-3667"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>T</given-names></name><name><surname>King</surname><given-names>L</given-names></name><name><surname>Caterson</surname><given-names>I</given-names></name></person-group><article-title>Obesity prevention: Necessary and possible A structured approach for effective planning</article-title><source>Proc Nutr Soc</source><volume>64</volume><fpage>255</fpage><lpage>261</lpage><year>2005</year><pub-id pub-id-type="doi">10.1079/PNS2005425</pub-id><pub-id pub-id-type="pmid">15960870</pub-id></element-citation></ref>
<ref id="b4-etm-0-0-3667"><label>4</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>O&#x0027;Connor</surname><given-names>DW</given-names></name></person-group><source>The impact of obesity on national and homeland security</source><publisher-name>Naval Postgraduate School</publisher-name><publisher-loc>Monterey, CA</publisher-loc><year>2013</year></element-citation></ref>
<ref id="b5-etm-0-0-3667"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>CJ</given-names></name><name><surname>Lopez</surname><given-names>AD</given-names></name></person-group><article-title>Mortality by cause for eight regions of the world: Global Burden of Disease Study</article-title><source>Lancet</source><volume>349</volume><fpage>1269</fpage><lpage>1276</lpage><year>1997</year><pub-id pub-id-type="doi">10.1016/S0140-6736(96)07493-4</pub-id><pub-id pub-id-type="pmid">9142060</pub-id></element-citation></ref>
<ref id="b6-etm-0-0-3667"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloomgarden</surname><given-names>ZT</given-names></name></person-group><article-title>Third Annual World Congress on the Insulin Resistance Syndrome: Associated conditions</article-title><source>Diabetes Care</source><volume>29</volume><fpage>2165</fpage><lpage>2174</lpage><year>2006</year><pub-id pub-id-type="doi">10.2337/dc06-zb09</pub-id><pub-id pub-id-type="pmid">16936171</pub-id></element-citation></ref>
<ref id="b7-etm-0-0-3667"><label>7</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Strumpf</surname><given-names>E</given-names></name></person-group><source>The obesity epidemic in the United States: causes and extent, risks and solutions</source><publisher-name>The Commonwealth Fund</publisher-name><publisher-loc>New York, NY</publisher-loc><year>2004</year></element-citation></ref>
<ref id="b8-etm-0-0-3667"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>JE</given-names></name><name><surname>Crook</surname><given-names>ED</given-names></name><name><surname>Jones</surname><given-names>DW</given-names></name><name><surname>Wofford</surname><given-names>MR</given-names></name><name><surname>Dubbert</surname><given-names>PM</given-names></name></person-group><article-title>Mechanisms of obesity-associated cardiovascular and renal disease</article-title><source>Am J Med Sci</source><volume>324</volume><fpage>127</fpage><lpage>137</lpage><year>2002</year><pub-id pub-id-type="doi">10.1097/00000441-200209000-00003</pub-id><pub-id pub-id-type="pmid">12240710</pub-id></element-citation></ref>
<ref id="b9-etm-0-0-3667"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frohlich</surname><given-names>ED</given-names></name></person-group><article-title>Clinical management of the obese hypertensive patient</article-title><source>Cardiol Rev</source><volume>10</volume><fpage>127</fpage><lpage>138</lpage><year>2002</year><pub-id pub-id-type="doi">10.1097/00045415-200205000-00001</pub-id><pub-id pub-id-type="pmid">12047791</pub-id></element-citation></ref>
<ref id="b10-etm-0-0-3667"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>JE</given-names></name><name><surname>Brands</surname><given-names>MW</given-names></name><name><surname>Hildebrandt</surname><given-names>DA</given-names></name><name><surname>Kuo</surname><given-names>J</given-names></name><name><surname>Fitzgerald</surname><given-names>S</given-names></name></person-group><article-title>Role of sympathetic nervous system and neuropeptides in obesity hypertension</article-title><source>Braz J Med Biol Res</source><volume>33</volume><fpage>605</fpage><lpage>618</lpage><year>2000</year><pub-id pub-id-type="doi">10.1590/S0100-879X2000000600001</pub-id><pub-id pub-id-type="pmid">10829088</pub-id></element-citation></ref>
<ref id="b11-etm-0-0-3667"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>JE</given-names></name></person-group><article-title>Pathophysiology of obesity hypertension</article-title><source>Curr Hypertens Rep</source><volume>2</volume><fpage>139</fpage><lpage>147</lpage><year>2000</year><pub-id pub-id-type="doi">10.1007/s11906-000-0073-4</pub-id><pub-id pub-id-type="pmid">10981140</pub-id></element-citation></ref>
<ref id="b12-etm-0-0-3667"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotsis</surname><given-names>V</given-names></name><name><surname>Stabouli</surname><given-names>S</given-names></name><name><surname>Bouldin</surname><given-names>M</given-names></name><name><surname>Low</surname><given-names>A</given-names></name><name><surname>Toumanidis</surname><given-names>S</given-names></name><name><surname>Zakopoulos</surname><given-names>N</given-names></name></person-group><article-title>Impact of obesity on 24-hour ambulatory blood pressure and hypertension</article-title><source>Hypertension</source><volume>45</volume><fpage>602</fpage><lpage>607</lpage><year>2005</year><pub-id pub-id-type="doi">10.1161/01.HYP.0000158261.86674.8e</pub-id><pub-id pub-id-type="pmid">15723966</pub-id></element-citation></ref>
<ref id="b13-etm-0-0-3667"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stabouli</surname><given-names>S</given-names></name><name><surname>Kotsis</surname><given-names>V</given-names></name><name><surname>Papamichael</surname><given-names>C</given-names></name><name><surname>Constantopoulos</surname><given-names>A</given-names></name><name><surname>Zakopoulos</surname><given-names>N</given-names></name></person-group><article-title>Adolescent obesity is associated with high ambulatory blood pressure and increased carotid intimal-medial thickness</article-title><source>J Pediatr</source><volume>147</volume><fpage>651</fpage><lpage>656</lpage><year>2005</year><pub-id pub-id-type="doi">10.1016/j.jpeds.2005.06.008</pub-id><pub-id pub-id-type="pmid">16291358</pub-id></element-citation></ref>
<ref id="b14-etm-0-0-3667"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Portela</surname><given-names>DS</given-names></name><name><surname>Vieira</surname><given-names>TO</given-names></name><name><surname>Matos</surname><given-names>SM</given-names></name><name><surname>de Oliveira</surname><given-names>NF</given-names></name><name><surname>Vieira</surname><given-names>GO</given-names></name></person-group><article-title>Maternal obesity, environmental factors, cesarean delivery and breastfeeding as determinants of overweight and obesity in children: Results from a cohort</article-title><source>BMC Pregnancy Childbirth</source><volume>15</volume><fpage>94</fpage><year>2015</year><pub-id pub-id-type="doi">10.1186/s12884-015-0518-z</pub-id><pub-id pub-id-type="pmid">25884808</pub-id></element-citation></ref>
<ref id="b15-etm-0-0-3667"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenbaum</surname><given-names>M</given-names></name><name><surname>Leibel</surname><given-names>RL</given-names></name></person-group><article-title>The physiology of body weight regulation: Relevance to the etiology of obesity in children</article-title><source>Pediatrics</source><volume>101</volume><fpage>525</fpage><lpage>539</lpage><year>1998</year><pub-id pub-id-type="pmid">12224659</pub-id></element-citation></ref>
<ref id="b16-etm-0-0-3667"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Racette</surname><given-names>SB</given-names></name><name><surname>Deusinger</surname><given-names>SS</given-names></name><name><surname>Strube</surname><given-names>MJ</given-names></name><name><surname>Highstein</surname><given-names>GR</given-names></name><name><surname>Deusinger</surname><given-names>RH</given-names></name></person-group><article-title>Weight changes, exercise, and dietary patterns during freshman and sophomore years of college</article-title><source>J Am Coll Health</source><volume>53</volume><fpage>245</fpage><lpage>251</lpage><year>2005</year><pub-id pub-id-type="doi">10.3200/JACH.53.6.245-251</pub-id><pub-id pub-id-type="pmid">15900988</pub-id></element-citation></ref>
<ref id="b17-etm-0-0-3667"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nestle</surname><given-names>M</given-names></name><name><surname>Jacobson</surname><given-names>MF</given-names></name></person-group><article-title>Halting the obesity epidemic: A public health policy approach</article-title><source>Public Health Rep</source><volume>115</volume><fpage>12</fpage><lpage>24</lpage><year>2000</year><pub-id pub-id-type="doi">10.1093/phr/115.1.12</pub-id><pub-id pub-id-type="pmid">10968581</pub-id></element-citation></ref>
<ref id="b18-etm-0-0-3667"><label>18</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Mirowsky</surname><given-names>J</given-names></name><name><surname>Ross</surname><given-names>CE</given-names></name></person-group><source>Social causes of psychological distress</source><publisher-name>Transaction Publishers</publisher-name><publisher-loc>New Jersey, NJ</publisher-loc><year>2003</year></element-citation></ref>
<ref id="b19-etm-0-0-3667"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spiegelman</surname><given-names>BM</given-names></name><name><surname>Flier</surname><given-names>JS</given-names></name></person-group><article-title>Obesity and the regulation of energy balance</article-title><source>Cell</source><volume>104</volume><fpage>531</fpage><lpage>543</lpage><year>2001</year><pub-id pub-id-type="doi">10.1016/S0092-8674(01)00240-9</pub-id><pub-id pub-id-type="pmid">11239410</pub-id></element-citation></ref>
<ref id="b20-etm-0-0-3667"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guyenet</surname><given-names>SJ</given-names></name><name><surname>Schwartz</surname><given-names>MW</given-names></name></person-group><article-title>Clinical review: Regulation of food intake, energy balance, and body fat mass: implications for the pathogenesis and treatment of obesity</article-title><source>J Clin Endocrinol Metab</source><volume>97</volume><fpage>745</fpage><lpage>755</lpage><year>2012</year><pub-id pub-id-type="doi">10.1210/jc.2011-2525</pub-id><pub-id pub-id-type="pmid">22238401</pub-id></element-citation></ref>
<ref id="b21-etm-0-0-3667"><label>21</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Life</surname><given-names>JS</given-names></name></person-group><source>The Life Plan Diet: How Losing Belly Fat is the Key to Gaining a Stronger, Sexier, Healthier Body</source><publisher-name>Simon and Schuster</publisher-name><publisher-loc>New York, NY</publisher-loc><year>2014</year></element-citation></ref>
<ref id="b22-etm-0-0-3667"><label>22</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gaman</surname><given-names>PM</given-names></name><name><surname>Sherrington</surname><given-names>KB</given-names></name></person-group><source>The science of food: an introduction to food science, nutrition and microbiology</source><publisher-name>Elsevier</publisher-name><year>2013</year></element-citation></ref>
<ref id="b23-etm-0-0-3667"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwok</surname><given-names>CY</given-names></name><name><surname>Wong</surname><given-names>CNY</given-names></name><name><surname>Yau</surname><given-names>MYC</given-names></name><name><surname>Yu</surname><given-names>PHF</given-names></name><name><surname>Au</surname><given-names>ALS</given-names></name><name><surname>Poon</surname><given-names>CCW</given-names></name><name><surname>Seto</surname><given-names>SW</given-names></name><name><surname>Lam</surname><given-names>TY</given-names></name><name><surname>Kwan</surname><given-names>YW</given-names></name><name><surname>Chan</surname><given-names>SW</given-names></name></person-group><article-title>Consumption of dried fruit of Crataegus pinnatifida (hawthorn) suppresses high-cholesterol diet-induced hypercholesterolemia in rats</article-title><source>J Funct Foods</source><volume>2</volume><fpage>179</fpage><lpage>186</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.jff.2010.04.006</pub-id></element-citation></ref>
<ref id="b24-etm-0-0-3667"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ledwozyw</surname><given-names>A</given-names></name><name><surname>Michalak</surname><given-names>J</given-names></name><name><surname>Stepie&#x0144;</surname><given-names>A</given-names></name><name><surname>Kadzio&#x0142;ka</surname><given-names>A</given-names></name></person-group><article-title>The relationship between plasma triglycerides, cholesterol, total lipids and lipid peroxidation products during human atherosclerosis</article-title><source>Clin Chim Acta</source><volume>155</volume><fpage>275</fpage><lpage>283</lpage><year>1986</year><pub-id pub-id-type="doi">10.1016/0009-8981(86)90247-0</pub-id><pub-id pub-id-type="pmid">3708856</pub-id></element-citation></ref>
<ref id="b25-etm-0-0-3667"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuzawa</surname><given-names>Y</given-names></name></person-group><article-title>Metabolic syndrome - definition and diagnostic criteria in Japan</article-title><source>J Atheroscler Thromb</source><volume>12</volume><fpage>301</fpage><lpage>301</lpage><year>2005</year><pub-id pub-id-type="doi">10.5551/jat.12.301</pub-id><pub-id pub-id-type="pmid">16394611</pub-id></element-citation></ref>
<ref id="b26-etm-0-0-3667"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>R</given-names></name></person-group><article-title>Atherosclerosis - an inflammatory disease</article-title><source>N Engl J Med</source><volume>340</volume><fpage>115</fpage><lpage>126</lpage><year>1999</year><pub-id pub-id-type="doi">10.1056/NEJM199901143400207</pub-id><pub-id pub-id-type="pmid">9887164</pub-id></element-citation></ref>
<ref id="b27-etm-0-0-3667"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotsis</surname><given-names>VT</given-names></name><name><surname>Stabouli</surname><given-names>SV</given-names></name><name><surname>Papamichael</surname><given-names>CM</given-names></name><name><surname>Zakopoulos</surname><given-names>NA</given-names></name></person-group><article-title>Impact of obesity in intima media thickness of carotid arteries</article-title><source>Obesity (Silver Spring)</source><volume>14</volume><fpage>1708</fpage><lpage>1715</lpage><year>2006</year><pub-id pub-id-type="doi">10.1038/oby.2006.196</pub-id><pub-id pub-id-type="pmid">17062799</pub-id></element-citation></ref>
<ref id="b28-etm-0-0-3667"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>LK</given-names></name></person-group><article-title>Global burden of intracranial atherosclerosis</article-title><source>Int J Stroke</source><volume>1</volume><fpage>158</fpage><lpage>159</lpage><year>2006</year><pub-id pub-id-type="doi">10.1111/j.1747-4949.2006.00045.x</pub-id><pub-id pub-id-type="pmid">18706036</pub-id></element-citation></ref>
<ref id="b29-etm-0-0-3667"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>WC</given-names></name><name><surname>Landau</surname><given-names>WM</given-names></name></person-group><article-title>Atherosclerosis and stroke</article-title><source>Ann Neurol</source><volume>28</volume><fpage>108</fpage><lpage>109</lpage><year>1990</year><pub-id pub-id-type="doi">10.1002/ana.410280122</pub-id><pub-id pub-id-type="pmid">2375626</pub-id></element-citation></ref>
<ref id="b30-etm-0-0-3667"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pico</surname><given-names>F</given-names></name><name><surname>Labreuche</surname><given-names>J</given-names></name><name><surname>Touboul</surname><given-names>PJ</given-names></name><name><surname>Amarenco</surname><given-names>P</given-names></name></person-group><article-title>GENIC Investigators: Intracranial arterial dolichoectasia and its relation with atherosclerosis and stroke subtype</article-title><source>Neurology</source><volume>61</volume><fpage>1736</fpage><lpage>1742</lpage><year>2003</year><pub-id pub-id-type="doi">10.1212/01.WNL.0000103168.14885.A8</pub-id><pub-id pub-id-type="pmid">14694039</pub-id></element-citation></ref>
<ref id="b31-etm-0-0-3667"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joki</surname><given-names>N</given-names></name><name><surname>Hase</surname><given-names>H</given-names></name><name><surname>Takahashi</surname><given-names>Y</given-names></name><name><surname>Ishikawa</surname><given-names>H</given-names></name><name><surname>Nakamura</surname><given-names>R</given-names></name><name><surname>Imamura</surname><given-names>Y</given-names></name><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Saijyo</surname><given-names>T</given-names></name><name><surname>Fukazawa</surname><given-names>M</given-names></name><name><surname>Inishi</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Angiographical severity of coronary atherosclerosis predicts death in the first year of hemodialysis</article-title><source>Int Urol Nephrol</source><volume>35</volume><fpage>289</fpage><lpage>297</lpage><year>2003</year><pub-id pub-id-type="doi">10.1023/B:UROL.0000020356.82724.37</pub-id><pub-id pub-id-type="pmid">15072511</pub-id></element-citation></ref>
<ref id="b32-etm-0-0-3667"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landsberg</surname><given-names>L</given-names></name><name><surname>Krieger</surname><given-names>DR</given-names></name></person-group><article-title>Obesity, metabolism, and the sympathetic nervous system</article-title><source>Am J Hypertens</source><volume>2</volume><fpage>125S</fpage><lpage>132S</lpage><year>1989</year><pub-id pub-id-type="pmid">2647103</pub-id></element-citation></ref>
<ref id="b33-etm-0-0-3667"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rocchini</surname><given-names>AP</given-names></name><name><surname>Yang</surname><given-names>JQ</given-names></name><name><surname>Gokee</surname><given-names>A</given-names></name></person-group><article-title>Hypertension and insulin resistance are not directly related in obese dogs</article-title><source>Hypertension</source><volume>43</volume><fpage>1011</fpage><lpage>1016</lpage><year>2004</year><pub-id pub-id-type="doi">10.1161/01.HYP.0000123073.48855.e9</pub-id><pub-id pub-id-type="pmid">15007033</pub-id></element-citation></ref>
<ref id="b34-etm-0-0-3667"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coatmellec-Taglioni</surname><given-names>G</given-names></name><name><surname>Ribi&#x00E8;re</surname><given-names>C</given-names></name></person-group><article-title>Factors that influence the risk of hypertension in obese individuals</article-title><source>Curr Opin Nephrol Hypertens</source><volume>12</volume><fpage>305</fpage><lpage>308</lpage><year>2003</year><pub-id pub-id-type="doi">10.1097/00041552-200305000-00013</pub-id><pub-id pub-id-type="pmid">12698070</pub-id></element-citation></ref>
<ref id="b35-etm-0-0-3667"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wofford</surname><given-names>MR</given-names></name><name><surname>Adair</surname><given-names>C</given-names></name><name><surname>Anderson</surname><given-names>DC</given-names></name><name><surname>Hall</surname><given-names>JE</given-names></name><name><surname>Miller</surname><given-names>MM</given-names></name><name><surname>Jones</surname><given-names>DW</given-names></name></person-group><article-title>Alpha and beta adrenergic blockade in obese and lean hypertensive subjects</article-title><source>Hypertension,</source><volume>32</volume><fpage>595</fpage><year>1998</year></element-citation></ref>
<ref id="b36-etm-0-0-3667"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>JE</given-names></name></person-group><article-title>Louis K</article-title><source>Dahl Memorial Lecture. Renal and cardiovascular mechanisms of hypertension in obesity. Hypertension</source><volume>23</volume><fpage>381</fpage><lpage>394</lpage><year>1994</year></element-citation></ref>
<ref id="b37-etm-0-0-3667"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poirier</surname><given-names>P</given-names></name><name><surname>Giles</surname><given-names>TD</given-names></name><name><surname>Bray</surname><given-names>GA</given-names></name><name><surname>Hong</surname><given-names>Y</given-names></name><name><surname>Stern</surname><given-names>JS</given-names></name><name><surname>Pi-Sunyer</surname><given-names>FX</given-names></name><name><surname>Eckel</surname><given-names>RH</given-names></name><collab>American Heart Association</collab></person-group><article-title>Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism: Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism</article-title><source>Circulation</source><volume>113</volume><fpage>898</fpage><lpage>918</lpage><year>2006</year><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.171016</pub-id><pub-id pub-id-type="pmid">16380542</pub-id></element-citation></ref>
<ref id="b38-etm-0-0-3667"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manes</surname><given-names>JL</given-names></name><name><surname>Taylor</surname><given-names>HB</given-names></name><name><surname>Starkloff</surname><given-names>GB</given-names></name></person-group><article-title>Relationship between hepatic morphology and clinical and biochemical findings in morbidly obese patients</article-title><source>J Clin Pathol</source><volume>26</volume><fpage>776</fpage><lpage>783</lpage><year>1973</year><pub-id pub-id-type="doi">10.1136/jcp.26.10.776</pub-id><pub-id pub-id-type="pmid">4750460</pub-id></element-citation></ref>
<ref id="b39-etm-0-0-3667"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deipolyi</surname><given-names>AR</given-names></name><name><surname>Fang</surname><given-names>S</given-names></name><name><surname>Palop</surname><given-names>JJ</given-names></name><name><surname>Yu</surname><given-names>GQ</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Mucke</surname><given-names>L</given-names></name></person-group><article-title>Altered navigational strategy use and visuospatial deficits in hAPP transgenic mice</article-title><source>Neurobiol Aging</source><volume>29</volume><fpage>253</fpage><lpage>266</lpage><year>2008</year><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2006.10.021</pub-id><pub-id pub-id-type="pmid">17126954</pub-id></element-citation></ref>
<ref id="b40-etm-0-0-3667"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>D</given-names></name><name><surname>Barbalho</surname><given-names>MC</given-names></name><name><surname>Miguel</surname><given-names>GP</given-names></name><name><surname>Forti</surname><given-names>EM</given-names></name><name><surname>Azevedo</surname><given-names>JL</given-names></name></person-group><article-title>The impact of obesity on pulmonary function in adult women</article-title><source>Clinics (Sao Paulo)</source><volume>63</volume><fpage>719</fpage><lpage>724</lpage><year>2008</year><pub-id pub-id-type="doi">10.1590/S1807-59322008000600002</pub-id><pub-id pub-id-type="pmid">19060990</pub-id></element-citation></ref>
<ref id="b41-etm-0-0-3667"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeClercq</surname><given-names>V</given-names></name><name><surname>McMurray</surname><given-names>DN</given-names></name><name><surname>Chapkin</surname><given-names>RS</given-names></name></person-group><article-title>Obesity promotes colonic stem cell expansion during cancer initiation</article-title><source>Cancer Lett</source><volume>369</volume><fpage>336</fpage><lpage>343</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.canlet.2015.10.001</pub-id><pub-id pub-id-type="pmid">26455770</pub-id></element-citation></ref>
<ref id="b42-etm-0-0-3667"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallagher</surname><given-names>S</given-names></name></person-group><article-title>The challenges of obesity and skin integrity</article-title><source>Nurs Clin North Am</source><volume>40</volume><fpage>325</fpage><lpage>335</lpage><year>2005</year><pub-id pub-id-type="doi">10.1016/j.cnur.2004.09.007</pub-id><pub-id pub-id-type="pmid">15924897</pub-id></element-citation></ref>
<ref id="b43-etm-0-0-3667"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Gaal</surname><given-names>LF</given-names></name><name><surname>Mertens</surname><given-names>IL</given-names></name><name><surname>De Block</surname><given-names>CE</given-names></name></person-group><article-title>Mechanisms linking obesity with cardiovascular disease</article-title><source>Nature</source><volume>444</volume><fpage>875</fpage><lpage>880</lpage><year>2006</year><pub-id pub-id-type="doi">10.1038/nature05487</pub-id><pub-id pub-id-type="pmid">17167476</pub-id></element-citation></ref>
<ref id="b44-etm-0-0-3667"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cazettes</surname><given-names>F</given-names></name><name><surname>Cohen</surname><given-names>JI</given-names></name><name><surname>Yau</surname><given-names>PL</given-names></name><name><surname>Talbot</surname><given-names>H</given-names></name><name><surname>Convit</surname><given-names>A</given-names></name></person-group><article-title>Obesity-mediated inflammation may damage the brain circuit that regulates food intake</article-title><source>Brain Res</source><volume>1373</volume><fpage>101</fpage><lpage>109</lpage><year>2011</year><pub-id pub-id-type="doi">10.1016/j.brainres.2010.12.008</pub-id><pub-id pub-id-type="pmid">21146506</pub-id></element-citation></ref>
<ref id="b45-etm-0-0-3667"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deji</surname><given-names>N</given-names></name><name><surname>Kume</surname><given-names>S</given-names></name><name><surname>Araki</surname><given-names>S</given-names></name><name><surname>Soumura</surname><given-names>M</given-names></name><name><surname>Sugimoto</surname><given-names>T</given-names></name><name><surname>Isshiki</surname><given-names>K</given-names></name><name><surname>Chin-Kanasaki</surname><given-names>M</given-names></name><name><surname>Sakaguchi</surname><given-names>M</given-names></name><name><surname>Koya</surname><given-names>D</given-names></name><name><surname>Haneda</surname><given-names>M</given-names></name><etal/></person-group><article-title>Structural and functional changes in the kidneys of high-fat diet-induced obese mice</article-title><source>Am J Physiol Renal Physiol</source><volume>296</volume><fpage>F118</fpage><lpage>F126</lpage><year>2009</year><pub-id pub-id-type="doi">10.1152/ajprenal.00110.2008</pub-id><pub-id pub-id-type="pmid">18971213</pub-id></element-citation></ref>
<ref id="b46-etm-0-0-3667"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kincaid-Smith</surname><given-names>P</given-names></name></person-group><article-title>Hypothesis: Obesity and the insulin resistance syndrome play a major role in end-stage renal failure attributed to hypertension and labelled &#x2018;hypertensive nephrosclerosis&#x2019;</article-title><source>J Hypertens</source><volume>22</volume><fpage>1051</fpage><lpage>1055</lpage><year>2004</year><pub-id pub-id-type="doi">10.1097/00004872-200406000-00001</pub-id><pub-id pub-id-type="pmid">15167435</pub-id></element-citation></ref>
<ref id="b47-etm-0-0-3667"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serra</surname><given-names>A</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Lopez</surname><given-names>D</given-names></name><name><surname>Navarro</surname><given-names>M</given-names></name><name><surname>Esteve</surname><given-names>A</given-names></name><name><surname>Perez</surname><given-names>N</given-names></name><name><surname>Alastrue</surname><given-names>A</given-names></name><name><surname>Ariza</surname><given-names>A</given-names></name></person-group><article-title>Renal injury in the extremely obese patients with normal renal function</article-title><source>Kidney Int</source><volume>73</volume><fpage>947</fpage><lpage>955</lpage><year>2008</year><pub-id pub-id-type="doi">10.1038/sj.ki.5002796</pub-id><pub-id pub-id-type="pmid">18216780</pub-id></element-citation></ref>
<ref id="b48-etm-0-0-3667"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Praga</surname><given-names>M</given-names></name><name><surname>Morales</surname><given-names>E</given-names></name></person-group><article-title>Obesity, proteinuria and progression of renal failure</article-title><source>Curr Opin Nephrol Hypertens</source><volume>15</volume><fpage>481</fpage><lpage>486</lpage><year>2006</year><pub-id pub-id-type="doi">10.1097/01.mnh.0000242172.06459.7c</pub-id><pub-id pub-id-type="pmid">16914959</pub-id></element-citation></ref>
<ref id="b49-etm-0-0-3667"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cignarelli</surname><given-names>M</given-names></name><name><surname>Lamacchia</surname><given-names>O</given-names></name></person-group><article-title>Obesity and kidney disease</article-title><source>Nutr Metab Cardiovasc Dis</source><volume>17</volume><fpage>757</fpage><lpage>762</lpage><year>2007</year><pub-id pub-id-type="doi">10.1016/j.numecd.2007.03.003</pub-id><pub-id pub-id-type="pmid">17606365</pub-id></element-citation></ref>
<ref id="b50-etm-0-0-3667"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bagby</surname><given-names>SP</given-names></name></person-group><article-title>Obesity-initiated metabolic syndrome and the kidney: A recipe for chronic kidney disease?</article-title><source>J Am Soc Nephrol</source><volume>15</volume><fpage>2775</fpage><lpage>2791</lpage><year>2004</year><pub-id pub-id-type="doi">10.1097/01.ASN.0000141965.28037.EE</pub-id><pub-id pub-id-type="pmid">15504931</pub-id></element-citation></ref>
<ref id="b51-etm-0-0-3667"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kambham</surname><given-names>N</given-names></name><name><surname>Markowitz</surname><given-names>GS</given-names></name><name><surname>Valeri</surname><given-names>AM</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>D&#x0027;Agati</surname><given-names>VD</given-names></name></person-group><article-title>Obesity-related glomerulopathy: An emerging epidemic</article-title><source>Kidney Int</source><volume>59</volume><fpage>1498</fpage><lpage>1509</lpage><year>2001</year><pub-id pub-id-type="doi">10.1046/j.1523-1755.2001.0590041498.x</pub-id><pub-id pub-id-type="pmid">11260414</pub-id></element-citation></ref>
<ref id="b52-etm-0-0-3667"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ordway</surname><given-names>RW</given-names></name><name><surname>Singer</surname><given-names>JJ</given-names></name><name><surname>Walsh</surname><given-names>JV</given-names><suffix>Jr</suffix></name></person-group><article-title>Direct regulation of ion channels by fatty acids</article-title><source>Trends Neurosci</source><volume>14</volume><fpage>96</fpage><lpage>100</lpage><year>1991</year><pub-id pub-id-type="doi">10.1016/0166-2236(91)90069-7</pub-id><pub-id pub-id-type="pmid">1709540</pub-id></element-citation></ref>
<ref id="b53-etm-0-0-3667"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>WA</given-names></name><name><surname>Blobe</surname><given-names>G</given-names></name><name><surname>Halpern</surname><given-names>A</given-names></name><name><surname>Taylor</surname><given-names>W</given-names></name><name><surname>Wetsel</surname><given-names>WC</given-names></name><name><surname>Burns</surname><given-names>D</given-names></name><name><surname>Loomis</surname><given-names>C</given-names></name><name><surname>Hannun</surname><given-names>YA</given-names></name></person-group><article-title>Selective regulation of protein kinase C isoenzymes by oleic acid in human platelets</article-title><source>J Biol Chem</source><volume>268</volume><fpage>5063</fpage><lpage>5068</lpage><year>1993</year><pub-id pub-id-type="pmid">8444883</pub-id></element-citation></ref>
<ref id="b54-etm-0-0-3667"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oishi</surname><given-names>K</given-names></name><name><surname>Zheng</surname><given-names>B</given-names></name><name><surname>Kuo</surname><given-names>JF</given-names></name></person-group><article-title>Inhibition of Na,K-ATPase and sodium pump by protein kinase C regulators sphingosine, lysophosphatidylcholine, and oleic acid</article-title><source>J Biol Chem</source><volume>265</volume><fpage>70</fpage><lpage>75</lpage><year>1990</year><pub-id pub-id-type="pmid">2152929</pub-id></element-citation></ref>
<ref id="b55-etm-0-0-3667"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrario</surname><given-names>CM</given-names></name><name><surname>Schiavone</surname><given-names>MT</given-names></name></person-group><article-title>The renin-angiotensin system: Importance in physiology and pathology</article-title><source>Cleve Clin J Med</source><volume>56</volume><fpage>439</fpage><lpage>446</lpage><year>1989</year><pub-id pub-id-type="doi">10.3949/ccjm.56.4.439</pub-id><pub-id pub-id-type="pmid">2663229</pub-id></element-citation></ref>
<ref id="b56-etm-0-0-3667"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yiannikouris</surname><given-names>F</given-names></name><name><surname>Karounos</surname><given-names>M</given-names></name><name><surname>Charnigo</surname><given-names>R</given-names></name><name><surname>English</surname><given-names>VL</given-names></name><name><surname>Rateri</surname><given-names>DL</given-names></name><name><surname>Daugherty</surname><given-names>A</given-names></name><name><surname>Cassis</surname><given-names>LA</given-names></name></person-group><article-title>Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice</article-title><source>Am J Physiol Regul Integr Comp Physiol</source><volume>302</volume><fpage>R244</fpage><lpage>R251</lpage><year>2012</year><pub-id pub-id-type="doi">10.1152/ajpregu.00323.2011</pub-id><pub-id pub-id-type="pmid">22071160</pub-id></element-citation></ref>
<ref id="b57-etm-0-0-3667"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guyton</surname><given-names>AC</given-names></name></person-group><article-title>The surprising kidney-fluid mechanism for pressure control - its infinite gain</article-title><source>Hypertension</source><volume>16</volume><fpage>725</fpage><lpage>730</lpage><year>1990</year><pub-id pub-id-type="doi">10.1161/01.HYP.16.6.725</pub-id><pub-id pub-id-type="pmid">2246039</pub-id></element-citation></ref>
<ref id="b58-etm-0-0-3667"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>JE</given-names></name></person-group><article-title>Mechanisms of abnormal renal sodium handling in obesity hypertension</article-title><source>Am J Hypertens</source><volume>10</volume><fpage>49S</fpage><lpage>55S</lpage><year>1997</year><pub-id pub-id-type="doi">10.1016/S0895-7061(97)00075-7</pub-id><pub-id pub-id-type="pmid">9160781</pub-id></element-citation></ref>
<ref id="b59-etm-0-0-3667"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuck</surname><given-names>ML</given-names></name><name><surname>Sowers</surname><given-names>J</given-names></name><name><surname>Dornfeld</surname><given-names>L</given-names></name><name><surname>Kledzik</surname><given-names>G</given-names></name><name><surname>Maxwell</surname><given-names>M</given-names></name></person-group><article-title>The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients</article-title><source>N Engl J Med</source><volume>304</volume><fpage>930</fpage><lpage>933</lpage><year>1981</year><pub-id pub-id-type="doi">10.1056/NEJM198104163041602</pub-id><pub-id pub-id-type="pmid">7010165</pub-id></element-citation></ref>
<ref id="b60-etm-0-0-3667"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taddei</surname><given-names>S</given-names></name><name><surname>Virdis</surname><given-names>A</given-names></name><name><surname>Mattei</surname><given-names>P</given-names></name><name><surname>Favilla</surname><given-names>S</given-names></name><name><surname>Salvetti</surname><given-names>A</given-names></name></person-group><article-title>Angiotensin II and sympathetic activity in sodium-restricted essential hypertension</article-title><source>Hypertension</source><volume>25</volume><fpage>595</fpage><lpage>601</lpage><year>1995</year><pub-id pub-id-type="doi">10.1161/01.HYP.25.4.595</pub-id><pub-id pub-id-type="pmid">7721403</pub-id></element-citation></ref>
<ref id="b61-etm-0-0-3667"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maser</surname><given-names>RE</given-names></name><name><surname>Lenhard</surname><given-names>MJ</given-names></name></person-group><article-title>An overview of the effect of weight loss on cardiovascular autonomic function</article-title><source>Curr Diabetes Rev</source><volume>3</volume><fpage>204</fpage><lpage>211</lpage><year>2007</year><pub-id pub-id-type="doi">10.2174/157339907781368931</pub-id><pub-id pub-id-type="pmid">18220673</pub-id></element-citation></ref>
<ref id="b62-etm-0-0-3667"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stepniakowski</surname><given-names>KT</given-names></name><name><surname>Goodfriend</surname><given-names>TL</given-names></name><name><surname>Egan</surname><given-names>BM</given-names></name></person-group><article-title>Fatty acids enhance vascular &#x03B1;-adrenergic sensitivity</article-title><source>Hypertension</source><volume>25</volume><fpage>774</fpage><lpage>778</lpage><year>1995</year><pub-id pub-id-type="doi">10.1161/01.HYP.25.4.774</pub-id><pub-id pub-id-type="pmid">7721431</pub-id></element-citation></ref>
<ref id="b63-etm-0-0-3667"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lichtenstein</surname><given-names>AH</given-names></name><name><surname>Appel</surname><given-names>LJ</given-names></name><name><surname>Brands</surname><given-names>M</given-names></name><name><surname>Carnethon</surname><given-names>M</given-names></name><name><surname>Daniels</surname><given-names>S</given-names></name><name><surname>Franch</surname><given-names>HA</given-names></name><name><surname>Franklin</surname><given-names>B</given-names></name><name><surname>Kris-Etherton</surname><given-names>P</given-names></name><name><surname>Harris</surname><given-names>WS</given-names></name><name><surname>Howard</surname><given-names>B</given-names></name><etal/></person-group><article-title>American Heart Association Nutrition Committee: Diet and lifestyle recommendations revision 2006: A scientific statement from the American Heart Association Nutrition Committee</article-title><source>Circulation</source><volume>114</volume><fpage>82</fpage><lpage>96</lpage><year>2006</year><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.176158</pub-id><pub-id pub-id-type="pmid">16785338</pub-id></element-citation></ref>
<ref id="b64-etm-0-0-3667"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mavanji</surname><given-names>V</given-names></name><name><surname>Billington</surname><given-names>CJ</given-names></name><name><surname>Kotz</surname><given-names>CM</given-names></name><name><surname>Teske</surname><given-names>JA</given-names></name></person-group><article-title>Sleep and obesity: A focus on animal models</article-title><source>Neurosci Biobehav Rev</source><volume>36</volume><fpage>1015</fpage><lpage>1029</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/j.neubiorev.2012.01.001</pub-id><pub-id pub-id-type="pmid">22266350</pub-id></element-citation></ref>
<ref id="b65-etm-0-0-3667"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koopman</surname><given-names>RJ</given-names></name><name><surname>Swofford</surname><given-names>SJ</given-names></name><name><surname>Beard</surname><given-names>MN</given-names></name><name><surname>Meadows</surname><given-names>SE</given-names></name></person-group><article-title>Obesity and metabolic disease</article-title><source>Prim Care</source><volume>36</volume><fpage>257</fpage><lpage>270</lpage><year>2009</year><pub-id pub-id-type="doi">10.1016/j.pop.2009.01.006</pub-id><pub-id pub-id-type="pmid">19501242</pub-id></element-citation></ref>
</ref-list>
</back>
</article>
